Study chemotherapy nerve damage in people with no or stable symptoms
Part of Brain & nervous system clinical trials.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and have cancer treated with chemotherapy
- Have a nerve-function score (TNSc) showing no neuropathy before the first chemo cycle, OR have stable chemotherapy-related neuropathy (TNSc 1 or higher) after at least 2 months off chemo
- Not have other brain or spinal conditions (like brain/spinal metastases or other neurologic problems) that could affect the nerve testing
- Avoid other medicines known to cause nerve damage (other than standard anti-cancer drugs)
- Have a good overall ability to function, with a Karnofsky score of 70 or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study looks at how chemotherapy-related nerve damage affects daily activities like walking and standing. It includes people who currently have or have had nerve-damaging chemotherapy and are experiencing nerve pain or weakness.
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
This study looks at mild or no nerve damage in the hands and feet after breast cancer chemotherapy. Researchers want to understand this condition better and find ways to help.
This study looks at tiny particles in your blood to understand and potentially predict nerve damage caused by certain chemotherapy drugs. Researchers will monitor you before, during, and after your cancer treatment to see if these particles can help warn doctors about this common side effect.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
Hear when a new CIPN trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.